Is indapamide still under patent protection?
Indapamide is a long-established medication (first marketed decades ago), so it is typically not under active “brand drug” patent protection anymore. In practice, what matters today is whether any newer patents exist for specific formulations (for example, extended-release versions), fixed-dose combinations, or manufacturing methods—plus what local regulations still protect in your country (such as data exclusivity or additional formulation/device protections).
If you tell me the country (US, EU, UK, Canada, etc.) and the exact product name (brand and strength, e.g., “indapamide SR 1.5 mg” or “indapamide 2.5 mg”), I can narrow what kind of patent/exclusivity might still be relevant.
Which patents typically cover indapamide today?
For an older generic active ingredient like indapamide, the most common remaining intellectual-property items tend to be:
- Patents on specific formulations (extended-release vs immediate-release, coatings, or release mechanisms).
- Patents on fixed-dose combinations that include indapamide with another drug.
- Patents on specific manufacturing processes or quality-control approaches.
- Regulatory-linked exclusivities that can delay generic entry even after an active compound patent expires.
When do indapamide patents expire?
There is no single worldwide “indapamide patent expiry” date because patents are granted country-by-country and vary by:
- Which patent family is being counted (compound, formulation, process, combination).
- Priority dates and how long term is adjusted.
- Exclusivity rules in each market.
To give an expiry date you can verify, you need the patent number(s) or at least the brand/product and jurisdiction.
Does generic indapamide become available immediately after patent expiry?
Not always. Even when a compound patent ends, generic launch can still be affected by:
- Remaining formulation or combination patents.
- Regulatory data-exclusivity periods in some jurisdictions.
- Ongoing patent litigation or “stay” mechanisms tied to approval pathways.
How to find the exact indapamide patent for your product
Search by product name and country in:
- Patent databases (e.g., Google Patents, the national patent office)
- Drug approval databases that link products to regulatory status (varies by country)
If you share:
1) the country,
2) the indapamide brand/product name, and
3) the strength/form (IR vs SR/ER),
I’ll help you pinpoint the most relevant patent(s) and explain what’s likely expired versus what could still limit competition.
What I need from you to answer precisely
When you say “Indapamide paten,” do you mean:
- patent expiry date for indapamide in a specific country, or
- whether a specific brand’s indapamide product is still protected?
Reply with the country and the exact brand/product name, and I’ll tailor the patent/exclusivity answer.
Sources: None (no provided sources to cite).